Awakn Life Sciences (Awakn Life Sciences) Cash And Cash Equivalents : $0.30 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Cash And Cash Equivalents?

Awakn Life Sciences's quarterly cash and cash equivalents increased from Jul. 2023 ($0.33 Mil) to Oct. 2023 ($0.41 Mil) but then stayed the same from Oct. 2023 ($0.41 Mil) to Jan. 2024 ($0.30 Mil).

Awakn Life Sciences's annual cash and cash equivalents declined from Jan. 2022 ($1.29 Mil) to Jan. 2023 ($0.41 Mil) and declined from Jan. 2023 ($0.41 Mil) to Jan. 2024 ($0.30 Mil).

Awakn Life Sciences Cash And Cash Equivalents Historical Data

The historical data trend for Awakn Life Sciences's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Cash And Cash Equivalents Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Cash And Cash Equivalents

0.29

1.29

0.41

0.30

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash And Cash Equivalents	Get a 7-Day Free Trial								0.41	0.29	0.33	0.41	0.30

Awakn Life Sciences Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Awakn Life Sciences (OTCPK:AWKNF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Awakn Life Sciences Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (Awakn Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

954:Germany AWKN:Canada

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines

From GuruFocus

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 07-01-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 06-21-2022

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

By PRNewswire PRNewswire • 10-11-2021

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By PurpleRose PurpleRose • 07-11-2022